General Announcement::ASX:TLX; NASDAQ:TLX - Telix Completes Enrollment in Phase 3 BiPASS Study

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
02-Sep-2026 06:18:32
Status
New
Announcement Sub Title
ASX:TLX; NASDAQ:TLX - Telix Completes Enrollment in Phase 3 BiPASS Study
Announcement Reference
SG260902OTHRR2FN
Submitted By (Co./ Ind. Name)
Joanne Redfearn
Designation
Company Secretary Administrator
Description (Please provide a detailed description of the event in the box below)
ASX:TLX; NASDAQ:TLX - Telix Completes Enrollment in Phase 3 BiPASS Study

Attachments

20260902 BiPASS Completion vFINAL ASX.pdf
Total size =195K